A biotechnology company is developing biologic treatments for Covid-19 infections in the gastrointestinal tract and to block further disease transmission. . . . → Read More: DoD Funds Covid-19 G.I. Infection Therapy
|
|||||
A biotechnology company is developing biologic treatments for Covid-19 infections in the gastrointestinal tract and to block further disease transmission. . . . → Read More: DoD Funds Covid-19 G.I. Infection Therapy A company developing messenger RNA therapeutics on demand from single-use biochips is raising $60 million in its second venture funding round. . . . → Read More: Chip-Based RNA Biotech Raises $60M in Venture Funds Here are some of the best ways of using technology to make a difference at home. . . . → Read More: How Technology Makes a Difference at Home An easy-to-use device for measuring intraocular pressure responsible for glaucoma is in development by University of Pittsburgh biomedical engineers. . . . → Read More: Home Eye Pressure Gauge in the Works A biotechnology company is sponsoring university research on light waves reacting in characteristic patterns for detecting SARS-CoV-2 viruses by a smartphone camera. . . . → Read More: Univ Lab, Company Developing Phone-Based Virus Sensor A blood test designed for low-resource field settings is shown to quickly detect and distinguish between different malaria parasites needed to accurately diagnose the disease. . . . → Read More: Quick Crispr-Based Test Detects Malaria in Blood Researchers in the U.K. created a bandage with enhanced human skeletal stem cells that in lab mice repairs simulated skull defects. . . . → Read More: Skeletal Stem Cells Enhanced for Bone Repair A company creating a blood test to screen for multiple types of cancer is being acquired by genomics analytics company Illumina for $8 billion in cash and stock. . . . → Read More: Cancer Screening Analytics Company Acquired in $8B Deal Science and Enterprise is taking off today to observe Rosh Hashanah, the Jewish new year. . . . → Read More: Shana Tova 5781 A company developing a drug for depression based on synthesized compounds in hallucinogenic substances is raising $127.5 million in its initial public stock offer. . . . → Read More: Mental Health Drug Company Raises $127.5M in IPO |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |